Vomiting and retching as presenting signs of focal epilepsy in children

Marion Depermentier1, Nathalie Mercier1, Roberto Santalucia1

  • 1Pediatric Neurology Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Insights

Ictal vomiting, a rare epilepsy symptom, is often misdiagnosed in children. Recognizing these seizures is crucial for timely diagnosis and treatment of epilepsy.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Epileptology

Background:

  • Ictal vomiting is an uncommon but significant manifestation of focal epilepsy.
  • It is frequently misdiagnosed as gastrointestinal or functional disorders, leading to diagnostic delays.
  • Early recognition is vital for appropriate management and improved patient outcomes.

Observation:

  • Two pediatric cases presented with recurrent vomiting and retching as the primary ictal symptom.
  • Patient 1 showed vomiting with right hemifacial clonic jerking, linked to ictal discharges on video-EEG.
  • Patient 2 experienced recurrent vomiting diagnosed as migraine, later confirmed as epileptic seizures with ictal discharges.

Findings:

  • Video-electroencephalography (Video-EEG) confirmed ictal discharges correlating with vomiting in both patients.
  • Neuroimaging (MRI, PET) revealed subtle or progressive abnormalities, including opercular hypometabolism and tumor progression.
  • Despite initial misdiagnoses, prompt diagnosis through EEG led to effective treatment and seizure control.

Implications:

  • This highlights the importance of considering ictal vomiting in the differential diagnosis of recurrent vomiting in children.
  • Prompt diagnosis of ictal vomiting can prevent prolonged misdiagnosis and ensure timely epilepsy treatment.
  • Increased awareness among clinicians can improve the management of pediatric epilepsy with unusual manifestations.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.0K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.1K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
910
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
631
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
648
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
448